Windtree Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell WINT and other ETFs, options, and stocks.

About WINT

Windtree Therapeutics, Inc. is a clinical-stage biopharmaceutical and medical device company engaged in the development of novel therapeutics intended to address significant unmet medical needs in important acute care markets. It focuses on the treatment of acute cardiovascular and acute pulmonary diseases. 

CEO
Jed Andrew Latkin
CEOJed Andrew Latkin
Employees
14
Employees14
Headquarters
Warrington, Pennsylvania
HeadquartersWarrington, Pennsylvania
Founded
1992
Founded1992
Employees
14
Employees14

WINT Key Statistics

Market cap
3.66M
Market cap3.66M
Price-Earnings ratio
-0.01
Price-Earnings ratio-0.01
Dividend yield
Dividend yield
Average volume
165.30K
Average volume165.30K
High today
$1.31
High today$1.31
Low today
$0.9606
Low today$0.9606
Open price
$1.19
Open price$1.19
Volume
695.75K
Volume695.75K
52 Week high
$737.44
52 Week high$737.44
52 Week low
$0.9606
52 Week low$0.9606

WINT News

TipRanks 15h
Windtree Therapeutics Raises $2.5M in Private Placement

The latest update is out from Windtree Therapeutics ( (WINT) ). On April 19, 2025, Windtree Therapeutics, through its subsidiary WINT Real Estate, LLC, entered...

People also own

Based on the portfolios of people who own WINT. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.